Citigroup Upgrades Adient to Buy, Raises Price Target to $33

Benzinga Newsdesk www.benzinga.com Positive 83.2%

Neg 0% Neu 0% Pos 83.2%

Citigroup analyst Michael Ward upgrades Adient (NYSE:ADNT) from Neutral to Buy and raises the price target from $30 to $33.